Caxton Associates LP Eagle Pharmaceuticals, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $25,084 - $45,064	1,414 Added 7.6%	20,027 $389,000
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $466,441 - $634,517	18,613 New	18,613 $528,000
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $197,650 - $251,496	-4,571 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $157,105 - $274,579	4,571 New	4,571 $210,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.